What You Should Know: - Xealth, a Seattle-based provider enabling digital health at scale, today announced that the company has secured $24 million in Series B funding led by Advocate Aurora Enterprises, a subsidiary of Advocate Aurora Health. Seven additional health systems – Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health and Stanford Health Care – join existing health system investors Atrium Health, Cleveland Clinic, Froedtert & MCW Health
Read More
Xealth’s CEO Shares Impact of Digital Health in 2020 and What’s Ahead in 2021
HIT Consultant sat down with Mike McSherry, CEO, and co-founder of Seattle-based digital prescription platform Xealth to discuss digital health lessons learned in 2020 and what we can expect in 2021. As Xealth’s CEO, Mike also works with Duke Health, UPMC, Atrium Health, and The Froedtert & the Medical College of Wisconsin health network where he uses his background in digital health to connect patients and care teams outside of traditional care settings. HITC: In 2021, How can digital
Read More
Cognoa, EVERSANA Partner to Advance the Commercialization Standard for Prescription Digital Medicines
- Cognoa and EVERSANA form a partnership that will enable prescription, dispensation, and reimbursement of Cognoa’s behavioral health products. - Cognoa is developing digital medicine solutions to change the standard of care in pediatric behavioral health to improve the lifelong outcomes for children. - Cognoa selected EVERSANA, a fully integrated and independent commercial services platform, to develop and manage a go-to-market strategy that ensures comprehensive market
Read More
Digital Prescribing Platform Xealth Raises Additional $3M to Close $14M Series A Round
Xealth, a Seattle-based digital prescribing platform has raised an additional $3 million in its Series A financing, bringing the amount raised in this round to $14 million total. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund join McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. Investments from this round will be used to advance the
Read More
Digital Prescribing Platform Xealth Raises $11M to Expand Digital Health Tools
Xealth, a Seattle-based digital prescribing platform has raised $11 million in Series A funding from McKesson Ventures, Novartis, Philips, and ResMed. Existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network also participated in the round.Xealth BackgroundSpun out of Providence St. Joseph Health in 2017, Xealth enables clinicians to prescribe and monitor digital healthcare content, apps, devices, and
Read More
Can Optimized EHR Data Help Healthcare Combat the Opioid Epidemic?
DrFirst’s Nick Barger explains how the EHR data at the right time can prevent opioids from getting into the wrong hands.While the debate on how to combat the infiltration and abuse of illegal narcotics in the U.S. languished for decades, something more sinister and formidable was growing. This new threat was not lurking in the shadows; instead, it was right under the noses and prescription pads of physicians— opioids.The abuse of prescription opioids has now become a national public health
Read More
Digital Health Startup Incubated at Providence Lands $8.5M for Digital Prescription Platform
Xealth, a digital health startup incubated within Providence’s Digital Innovation program has raised $8.5 million in funding led by DFJ to launch its digital prescription platform. The funding also included participation from leading healthcare organizations including Providence, UPMC, Hennepin, and Froedtert.Xealth’s digital prescribing and analytics platform is already being used by two of the largest not-for-profit healthcare systems in the US—Seattle-based Providence and Pittsburgh-based
Read More
